Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

F. Martora · SciRah

Researcher profile · Semantic Scholar

F. Martora

Share profile

F. Martora — researcher profile on SciRah

h-index: 29
Works: 177
Citations: 2,055

Most-cited papers

Hidradenitis Suppurativa and JAK Inhibitors: A Review of the Published Literature
F. Martora, M. Scalvenzi, A. Ruggiero, L. Potestio +2 more
2023Medicina53 citations Open access
Semantic Scholar
Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience
F. Martora, M. Megna, T. Battista, L. Potestio +4 more
2023Clinical, Cosmetic and Investigational Dermatology47 citations Open access
Semantic Scholar
The Role of Interleukin 23/17 Axis in Psoriasis Management: A Comprehensive Review of Clinical Trials
L. Potestio, F. Martora, Giuseppe Lauletta, Ylenia Vallone +2 more
2024Clinical, Cosmetic and Investigational Dermatology40 citations Open access
Semantic Scholar
Bimekizumab treatment in patients with moderate to severe plaque psoriasis: a drug safety evaluation
A. Ruggiero, L. Potestio, F. Martora, A. Villani +2 more
2023Expert Opinion on Drug Safety38 citations
Semantic Scholar
Secukinumab in Hidradenitis Suppurativa Patients Who Failed Adalimumab: A 52-Week Real-Life Study
F. Martora, Claudio Marasca, S. Cacciapuoti, Federica Fariello +4 more
2024Clinical, Cosmetic and Investigational Dermatology27 citations Open access
Semantic Scholar
Risk Factors for Psoriasis Flares: A Narrative Review
L. Potestio, Giuseppe Lauletta, Nello Tommasino, Antonio Portarapillo +4 more
2024Psoriasis25 citations Open access
Semantic Scholar
Nail Psoriasis: An Updated Review of Currently Available Systemic Treatments
T. Battista, M. Scalvenzi, F. Martora, L. Potestio +1 more
2023Clinical, Cosmetic and Investigational Dermatology25 citations Open access
Semantic Scholar
Management of Advanced Invasive Melanoma: New Strategies
A. Villani, M. Scalvenzi, G. Micali, F. Lacarrubba +3 more
2023Advances in Therapy25 citations Open access
Semantic Scholar
Very low-calorie ketogenic diet (VLCKD) in the management of hidradenitis suppurativa (Acne Inversa): an effective and safe tool for improvement of the clinical severity of disease. Results of a pilot study
L. Verde, S. Cacciapuoti, G. Caiazzo, M. Megna +9 more
2024Journal of Translational Medicine24 citations Open access
Semantic Scholar
Use of Biological Therapies for the Management of Pustular Psoriasis: A New Era?
M. Megna, E. Camela, A. Ruggiero, T. Battista +3 more
2023Clinical, Cosmetic and Investigational Dermatology23 citations Open access
Semantic Scholar
Biological Therapy for Psoriasis in Cancer Patients: An 8-Year Retrospective Real-Life Study
T. Battista, L. Gallo, F. Martora, D. Fattore +4 more
2024Journal of Clinical Medicine22 citations Open access
Semantic Scholar
Management of Psoriasis Patients with Serious Infectious Diseases
M. Megna, Giuseppe Lauletta, Nello Tommasino, Antonia Salsano +4 more
2024Advances in Therapy21 citations Open access
Semantic Scholar
Guselkumab, Risankizumab, and Tildrakizumab in the Management of Hidradenitis Suppurativa: A Review of Existing Trials and Real-Life Data
F. Martora, M. Scalvenzi, T. Battista, Luigi Fornaro +3 more
2023Clinical, Cosmetic and Investigational Dermatology20 citations Open access
Semantic Scholar
Long-Term Efficacy and Safety of Guselkumab in Psoriasis Patients Who Failed Anti-IL17: A Two-Year Real-Life Study
M. Megna, A. Ruggiero, F. Martora, Ylenia Vallone +2 more
2024Journal of Clinical Medicine17 citations Open access
Semantic Scholar
The Past, the Present and the Future of Teledermatology: A Narrative Review
Nello Tommasino, M. Megna, S. Cacciapuoti, A. Villani +4 more
2024Clinical, Cosmetic and Investigational Dermatology17 citations Open access
Semantic Scholar
Effectiveness and Safety of Upadacitinib for Adolescents with Atopic Dermatitis in a Real-World Setting
C. Patruno, Giuseppe Lauletta, E. Pezzolo, V. Boccaletti +9 more
2024Clinical drug investigation16 citations
Semantic Scholar
Psoriasis and Molecular Target Therapies: Evidence of Efficacy in Preventing Cardiovascular Comorbidities
L. Potestio, Nello Tommasino, Giuseppe Lauletta, F. Martora +1 more
2024Dermatologic Therapy14 citations Open access
Semantic Scholar
Effectiveness and Safety of Deucravacitinib for the Management of Psoriasis: A Review of the Current Literature
L. Potestio, A. Ruggiero, G. Fabbrocini, F. Martora +1 more
2023Psoriasis12 citations Open access
Semantic Scholar
Long-term efficacy and safety of bimekizumab in real-world setting: a 52-week prospective study
L. Potestio, A. Ruggiero, F. Martora, M. Megna
2024Archives of Dermatological Research11 citations
Semantic Scholar
New Onset and Exacerbation of Psoriasis Following COVID-19 Vaccination: A Review of the Current Knowledge
L. Potestio, T. Battista, S. Cacciapuoti, A. Ruggiero +4 more
2023Biomedicines11 citations Open access
Semantic Scholar
Injection site reactions after dupilumab or tralokinumab for atopic dermatitis
F. Martora, C. Patruno, Silvia D’Ascenzo, M. Napolitano
2024Journal of dermatological treatment (Print)10 citations Open access
Semantic Scholar
Efficacy and Safety of bimekizumab in psoriasis management in real-life: bio-naïve vs bio-experienced.
M. Megna, A. Ruggiero, Ginevra Torta, F. Martora +2 more
2024Clincal and Experimental Dermatology9 citations
Semantic Scholar
Emerging Role of Biologic Drugs Targeting IL-17 and IL-23: Pityriasis Rubra Pilaris
L. Potestio, M. D’Agostino, Antonio Portarapillo, Valeria Esposito +5 more
2024Life9 citations Open access
Semantic Scholar
Tirbanibulin ointment to manage recurrence of superficial Basal Cell Carcinoma of the face: report of a case.
F. Martora, P. Ascierto, M. Scalvenzi, M. Palla +5 more
2023Clincal and Experimental Dermatology9 citations
Semantic Scholar
Novel pharmacotherapies and breakthroughs in psoriasis treatment: 2024 and beyond
Antonio Portarapillo, L. Potestio, Nello Tommasino, Giuseppe Lauletta +5 more
2024Expert Opinion on Pharmacotherapy8 citations
Semantic Scholar
Anti-IL-17/23 Drugs for the Treatment of Moderate-to-Severe Hidradenitis Suppurativa in Patients With Concomitant Psoriasis: A Multicenter Retrospective Study
L. Gargiulo, L. Ibba, A. Narcisi, Silvia Giordano +14 more
2024Dermatology Practical & Conceptual8 citations Open access
Semantic Scholar
Paradoxical hidradenitis suppurativa induced by adalimumab biosimilar successfully treated with guselkumab in a psoriasis patient. Comment on “Paradoxical hidradenitis suppurativa due to anti-interleukin-1 agents for mevalonate kinase deficiency successfully treated with the addition of ustekinumab”
F. Martora, G. Fabbrocini, C. Marasca, T. Battista +1 more
2023Clincal and Experimental Dermatology8 citations
Semantic Scholar
Guselkumab-induced vitiligo in a patient with psoriatic arthritis
F. Martora, M. C. Annunziata, Luigi Guerriero, T. Battista +2 more
2023JAAD Case Reports8 citations Open access
Semantic Scholar
Hidradenitis Suppurativa Cancer Risk: A Review of the Literature
F. Martora, Nello Tommasino, T. Battista, L. Potestio +1 more
2025Clinical, Cosmetic and Investigational Dermatology7 citations Open access
Semantic Scholar
Efficacy and safety of deucravacitinib for the management of psoriasis: a drug safety evaluation
L. Potestio, Nello Tommasino, Giuseppe Lauletta, Federica Feo +5 more
2024Expert Opinion on Drug Safety7 citations
Semantic Scholar
Effectiveness and Safety of Tildrakizumab in Psoriasis Patients Who Failed Anti-IL17 Treatment: A 28-Week Real-Life Study
M. Megna, A. Ruggiero, Nello Tommasino, Claudio Brescia +3 more
2024Clinical, Cosmetic and Investigational Dermatology7 citations Open access
Semantic Scholar
Efficacy and Safety of Cemiplimab for the Management of Non-Melanoma Skin Cancer: A Drug Safety Evaluation
L. Potestio, M. Scalvenzi, A. Lallas, F. Martora +4 more
2024Cancers7 citations Open access
Semantic Scholar
How Adalimumab Impacts Antibiotic Prescriptions in Patients Affected by Hidradenitis Suppurativa: A 1-Year Prospective Study and Retrospective Analysis
F. Martora, C. Marasca, V. Picone, Luigi Fornaro +2 more
2023Journal of Clinical Medicine7 citations Open access
Semantic Scholar
Pemphigus and Bullous Pemphigoid Following COVID-19 Vaccination: A Systematic Review
F. Martora, T. Battista, L. Potestio, M. Napolitano +3 more
2024Viruses6 citations Open access
Semantic Scholar
Efficacy and safety of spesolimab for the management of generalized pustular psoriasis: a drug safety evaluation
L. Potestio, E. Camela, S. Cacciapuoti, F. Martora +4 more
2023Expert Opinion on Drug Safety6 citations
Semantic Scholar
A Case of Erythrodermic Psoriasis Successfully Treated with Risankizumab
M. Megna, A. Ruggiero, Antonia Salsano, Giuseppe Lauletta +4 more
2023Clinical, Cosmetic and Investigational Dermatology6 citations Open access
Semantic Scholar
Indirect Comparison Between Bimekizumab and Brodalumab for the Management of Moderate to Severe Psoriasis: A 36-Week Real-Life Study
L. Potestio, F. Martora, Flavia Raia, Gioacchino Lucagnano +3 more
2025Dermatologic Therapy5 citations Open access
Semantic Scholar
Severe Paradoxical Scalp Psoriasis Induced by Bimekizumab in a Young Multifailure Hidradenitis Suppurativa Patient
F. Martora, T. Battista, L. Potestio, M. Megna
2025Dermatologic Therapy5 citations Open access
Semantic Scholar
Injection site reactions resulting from the use of biological therapy in the treatment of moderate-to-severe plaque psoriasis
T. Battista, V. Picone, Matteo Noto, L. Potestio +4 more
2024Expert Opinion on Drug Safety5 citations
Semantic Scholar
Herpes Zoster and COVID-19 Vaccination: A Narrative Review
L. Potestio, M. Megna, A. Villani, S. Cacciapuoti +2 more
2023Clinical, Cosmetic and Investigational Dermatology5 citations Open access
Semantic Scholar
Efficacy and Safety of Tildrakizumab in a Patient with Chronic HBV Infection
L. Potestio, Ilaria Piscitelli, G. Fabbrocini, F. Martora +2 more
2023Clinical, Cosmetic and Investigational Dermatology5 citations Open access
Semantic Scholar
Concomitant Severe Psoriasis and Bullous Pemphigoid Induced by COVID-19
F. Martora, T. Battista, G. Fabbrocini, M. Megna
2023Tropical Medicine and Infectious Disease5 citations Open access
Semantic Scholar
The Impact of Psoriasis Treatments on the Risk of Skin Cancer: A Narrative Review
L. Potestio, Nello Tommasino, Giuseppe Lauletta, Antonia Salsano +5 more
2024Advances in Therapy4 citations
Semantic Scholar
ChatGPT and dermatology.
M. D’Agostino, Federica Feo, F. Martora, L. Genco +4 more
2024Italian journal of dermatology and venereology4 citations
Semantic Scholar
The use of ChatGPT in the dermatological field: a narrative review.
L. Potestio, Federica Feo, F. Martora, M. Megna +2 more
2024Clincal and Experimental Dermatology4 citations
Semantic Scholar
Unaddressed Challenges in the Treatment of Cutaneous Melanoma?
A. Villani, L. Potestio, A. Lallas, Z. Apalla +2 more
2024Medicina4 citations Open access
Semantic Scholar
Hidradenitis Suppurativa in Elderly Patients: Clinical and Therapeutical Outcomes—A Review of the Literature
F. Martora, Nello Tommasino, Claudio Brescia, L. Potestio +2 more
2024Medicina4 citations Open access
Semantic Scholar
A case of scalp psoriasis resistant to ixekizumab treated with bimekizumab
M. Megna, V. Picone, Virginia Ventura, F. Martora +3 more
2023JAAD Case Reports4 citations Open access
Semantic Scholar
Secukinumab for Severe Hidradenitis Suppurativa in a Patient on Haemodialysis: Efficacy and Safety on 300 mg Every 2 Weeks Administration – A Case Report
F. Martora, M. C. Annunziata, L. Potestio, T. Battista +2 more
2024Clinical, Cosmetic and Investigational Dermatology3 citations Open access
Semantic Scholar
An update on the current and emerging pharmacotherapies for basal cell carcinomas
A. Villani, M. Scalvenzi, G. Micali, F. Martora +3 more
2023Expert Opinion on Pharmacotherapy3 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

L. Potestio×41
Invite
L. Potestio — researcher profile on SciRah
M. Megna×37
Invite
M. Megna — researcher profile on SciRah
T. Battista×21
Invite
T. Battista — researcher profile on SciRah
A. Ruggiero×19
Invite
A. Ruggiero — researcher profile on SciRah

×11

Invite

M. Scalvenzi — researcher profile on SciRah

Nello Tommasino×11

Invite

Nello Tommasino — researcher profile on SciRah

S. Cacciapuoti×10

Invite

S. Cacciapuoti — researcher profile on SciRah

Invite

A. Villani — researcher profile on SciRah

Giuseppe Lauletta×9

Invite

Giuseppe Lauletta — researcher profile on SciRah

G. Fabbrocini×7

Invite

G. Fabbrocini — researcher profile on SciRah

Antonia Salsano×6

Invite

Antonia Salsano — researcher profile on SciRah

Luigi Fornaro×6

Invite

Luigi Fornaro — researcher profile on SciRah